CLASS II ONGOING Drug recall · Reported 14 Jan 2026 · FDA Enforcement Report

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg recalled

SpecGx is recalling Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, distributed nationwide in the US. The recall was initiated on 16 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.
NDC0406-0512, 0406-0522, 0406-0523
UPC0304060522053, 0304060523050, 0304060512054
Quantity recalled287,988 Bottles.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0254-2026
FDA event ID
98136
Recalling firm
SpecGx, Webster Groves, MO
Manufacturer
SpecGx LLC
Classification
Class II
Status
Ongoing
Recall initiated
16 Dec 2025
FDA classified
7 Jan 2026
Reported
14 Jan 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

16 Dec 2025Recall initiated by company
7 Jan 2026Classified by FDA+22 days
14 Jan 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Product as listed by the FDA

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg recalled?

Yes. SpecGx recalled Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg on 16 Dec 2025. The recall is Class II and its status is Ongoing. Recall number D-0254-2026.

Why was it recalled?

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Which lots are affected?

Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from SpecGx

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIOxycodone and Acetaminophen CII Tablets USP, 5 mg/325 mg recalledOxycodone And AcetaminophenSpecGxOtherNationwide

Other Oxycodone Hydrochloride recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIOxycodone and Acetaminophen CII Tablets USP, 5 mg/325 mg recalledOxycodone And AcetaminophenSpecGxOtherNationwide